24.8 C
New York
Saturday, June 6, 2026

Tag: consultation

newssourceFORcompanyinformationcontent1marketreleases

Platypus Home Celebrates Grand Reopening Under New Ownership With a Reimagined Showroom

Monmouth County's Premier Home Design Destination Invites the Community to an Evening of Celebration on June 8, 2026MONMOUTH COUNTY, N.J., June 5, 2026 /PRNewswire/...

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

Special meeting will allow shareholders to vote on share consolidation to support potential uplisting to a U.S. stock exchange 
Special meeting will allow shareholders to vote on share consolidation to support potential uplisting to a U.S. stock exchange

TERRAVEST PROVIDES UPDATE

TORONTO, June 5, 2026 /CNW/ - TerraVest Industries Inc. (TSX: TVK) ("TerraVest" or the "Company") announces that it has learned today of certain allegations...

Fighting the Global Fertility Crisis! Taiwan Pioneers AI-Powered Embryo Selection Model — Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

Breaking Through the "Blind Selection" Dilemma in Clinical Practice — TFC Taipei Fertility Center Introduces AI Scoring System to Help Infertile Couples End the...

LANEIGE Opens Global Flagship, Redefining the Future of Personalized Beauty

The iconic Seoul-based brand introduces a first-of-its-kind flagship where cutting-edge architecture meets AI-based, made-for-you beautySEOUL, South Korea, June 5, 2026 /PRNewswire/ -- After 18 months...

S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies – Results

NEW YORK, June 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") conducted a consultation with market participants on potential changes to the S&P U.S....

Press Release: Sanofi launches 2026 global employee stock purchase plan

Sanofi launches 2026 global employee stock purchase plan

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity

Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany

Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.

Mercedes-Benz of Westwood Celebrates Grand Opening of Newly Renovated Luxury Dealership

Multi-phase renovation introduces expanded showroom, enhanced service drive, AMG Performance Center displays, EV infrastructure, and updated customer amenitiesWESTWOOD, Mass., June 3, 2026 /PRNewswire/ --...

Form 8.3 Picton Property Income Limited

8.3

Trina Storage Signs 160 MWh Utility-Scale Energy Storage Project in Kyushu, Japan

TOKYO, June 3, 2026 /PRNewswire/ -- Trina Storage, the energy storage business unit of Trinasolar, has signed a contract for a 160 MWh ultra-high...

New Research Revealed Effective Surgical Management Techniques for Gynecomastia in Asian Men, Resulting in High Patient Satisfaction

Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....

Cielo Waste Solutions to Present Project Nahoonai at ICAO Aviation Climate Week 2026

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsConsultation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers